You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

VOLTAREN ARTHRITIS PAIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Voltaren Arthritis Pain, and what generic alternatives are available?

Voltaren Arthritis Pain is a drug marketed by Haleon Us Holdings and is included in one NDA.

The generic ingredient in VOLTAREN ARTHRITIS PAIN is diclofenac sodium. There are forty-seven drug master file entries for this compound. One hundred and twenty-nine suppliers are listed for this compound. Additional details are available on the diclofenac sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Voltaren Arthritis Pain

A generic version of VOLTAREN ARTHRITIS PAIN was approved as diclofenac sodium by ACTAVIS ELIZABETH on March 26th, 1996.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for VOLTAREN ARTHRITIS PAIN?
  • What are the global sales for VOLTAREN ARTHRITIS PAIN?
  • What is Average Wholesale Price for VOLTAREN ARTHRITIS PAIN?
Summary for VOLTAREN ARTHRITIS PAIN
US Patents:0
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 3
Raw Ingredient (Bulk) Api Vendors: 121
Clinical Trials: 1
Patent Applications: 4,203
What excipients (inactive ingredients) are in VOLTAREN ARTHRITIS PAIN?VOLTAREN ARTHRITIS PAIN excipients list
DailyMed Link:VOLTAREN ARTHRITIS PAIN at DailyMed
Drug patent expirations by year for VOLTAREN ARTHRITIS PAIN
Recent Clinical Trials for VOLTAREN ARTHRITIS PAIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Zambon SpAPhase 1
Cross Research S.A.Phase 1

See all VOLTAREN ARTHRITIS PAIN clinical trials

Pharmacology for VOLTAREN ARTHRITIS PAIN

US Patents and Regulatory Information for VOLTAREN ARTHRITIS PAIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Haleon Us Holdings VOLTAREN ARTHRITIS PAIN diclofenac sodium GEL;TOPICAL 022122-001 Oct 17, 2007 OTC Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.